Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer: A Single Technology Appraisal

Alexis Llewellyn; Roje Javon Layne Layne; Chinyereugo Umemneku-Chikere; Carlos Chivardi; Helen Fulbright; Sofia Dias; Claire Rothery; Kerry Margaret Kirkham; Ana Isabel Duarte

Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer: A Single Technology Appraisal

Alexis Llewellyn, Roje Javon Layne Layne, Chinyereugo Umemneku-Chikere, Carlos Chivardi, Helen Fulbright, Sofia Dias, Claire Rothery, Kerry Margaret Kirkham^*, Ana Isabel Duarte

^*Corresponding author for this work

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 9 May 2025

Access to Document

https://www.nice.org.uk/guidance/gid-ta11432/documents/committee-papers

Cite this

Llewellyn, A., Layne, R. J. L., Umemneku-Chikere, C., Chivardi, C., Fulbright, H., Dias, S., Rothery, C., Kirkham, K. M., & Duarte, A. I. (2025). Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer: A Single Technology Appraisal. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/gid-ta11432/documents/committee-papers

@book{32889bd812454f39a0009b4868d17e36,

title = "Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer: A Single Technology Appraisal",

author = "Alexis Llewellyn and Layne, {Roje Javon Layne} and Chinyereugo Umemneku-Chikere and Carlos Chivardi and Helen Fulbright and Sofia Dias and Claire Rothery and Kirkham, {Kerry Margaret} and Duarte, {Ana Isabel}",

year = "2025",

month = may,

day = "9",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

Llewellyn, A , Layne, RJL , Umemneku-Chikere, C , Chivardi, C , Fulbright, H , Dias, S , Rothery, C , Kirkham, KM & Duarte, AI 2025, Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer: A Single Technology Appraisal. National Institute for Health and Care Excellence. <https://www.nice.org.uk/guidance/gid-ta11432/documents/committee-papers>

TY - BOOK

T1 - Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer

T2 - A Single Technology Appraisal

AU - Llewellyn, Alexis

AU - Layne, Roje Javon Layne

AU - Umemneku-Chikere, Chinyereugo

AU - Chivardi, Carlos

AU - Fulbright, Helen

AU - Dias, Sofia

AU - Rothery, Claire

AU - Kirkham, Kerry Margaret

AU - Duarte, Ana Isabel

PY - 2025/5/9

Y1 - 2025/5/9

M3 - Commissioned report

BT - Adagrasib for previously treated KRAS G12C mutation positive advanced non-small-cell lung cancer

PB - National Institute for Health and Care Excellence

ER -